The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinson's Disease: A Retrospective Claims-Based Analysis

Author： Delea Thomas E.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.1, 2011-01, pp. : 53-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa/carbidopa/entacapone: Pisa syndrome (first report with entacapone) in a patient with Parkinson's disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1239, 2009-01 ,pp. : 20-21

Adis International

Access to resources Recommend Favorite

Levodopa/carbidopa/entacapone: Lymphocytic colitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Levodopa/carbidopa and Parkinson's disease progression

By  

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Long-term infusion of levodopa/carbidopa is effective in patients with advanced Parkinson's disease

By  

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia

By Darkow Theodore  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 481-496

Adis International

Access to resources Recommend Favorite